Back to Market Feed

TYENNE 162 MG/0.9 ML AUTOINJCT

Tocilizumab-aazg

$821.7090per ML

Strength

162 mg/.9mL

Manufacturer

Fresenius Kabi USA, LLC

NDC

65219059601

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

9/1/2025

Pharmacological Classes

Interleukin 6 Receptor Antagonists

Interleukin-6 Receptor Antagonist

Price History

1W

0.0%

1M

0.0%

3M

+0.2%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

1 alternative • Same active ingredient

TYENNE 162 MG/0.9 ML AUTOINJCT

65219058401•Fresenius Kabi USA, LLC

Related Drugs

Same classification

No related drugs found.